FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

734150006: Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3487411011 Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677808015 Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4558181000052113 elvitegravir 150 milligram, emtricitabin 200 milligram, kobicistat 150 milligram och tenofoviralafenamid 10 milligram, oral tablett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Is a Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form false Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has active ingredient Cobicistat false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Cobicistat false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 150 (qualifier value) false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Some 8
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has active ingredient Elvitegravir (substance) false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Elvitegravir (substance) false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 150 (qualifier value) false Inferred relationship Some 6
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has active ingredient Emtricitabine (substance) false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Emtricitabine (substance) false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 200 (qualifier value) false Inferred relationship Some 7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has active ingredient Tenofovir alafenamide (substance) false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Tenofovir alafenamide (substance) false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 10 (qualifier value) false Inferred relationship Some 5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 150 (qualifier value) false Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 150 (qualifier value) false Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har nämnarvärde som visar styrka 1 (qualifier value) false Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Cobicistat false Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Cobicistat false Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Emtricitabine (substance) false Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 200 (qualifier value) false Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Elvitegravir (substance) true Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Elvitegravir (substance) true Inferred relationship Some 2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Emtricitabine (substance) false Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet har täljarvärde som visar styrka 10 (qualifier value) false Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Tenofovir alafenamide (substance) true Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Tenofovir alafenamide (substance) true Inferred relationship Some 4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet räkning av bas i aktiv ingrediens 4 (qualifier value) false Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Is a Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form) true Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Plays role Antiretroviral therapeutic role true Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Cobicistat true Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has basis of strength substance (attribute) Emtricitabine (substance) true Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Emtricitabine (substance) true Inferred relationship Some 1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Has precise active ingredient Cobicistat true Inferred relationship Some 3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Is a Cobicistat-containing product in oral dose form false Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Is a Elvitegravir-containing product in oral dose form false Inferred relationship Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet Is a Emtricitabine-containing product in oral dose form false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start